With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds

24th October 2025 Uncategorised 0

Following a slight delay earlier this year—and a world-first green light in the U.K. over the summer—Bayer has clinched an FDA nod to bolster the limited arsenal of nonhormonal treatments for one of the most common symptoms of menopause.

More: With FDA nod, Bayer's Lynkuet enters US market for nonhormonal menopause symptom meds
Source: fierce